Filing Details
- Accession Number:
- 0001209191-22-057945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-18 17:21:38
- Reporting Period:
- 2022-09-27
- Accepted Time:
- 2022-11-18 17:21:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1490829 | James Jones | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-27 | 31 | $2.57 | 24,231 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-28 | 31 | $2.52 | 24,262 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-29 | 31 | $2.51 | 24,293 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-30 | 31 | $2.61 | 24,324 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-03 | 31 | $2.54 | 24,355 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-04 | 31 | $2.61 | 24,386 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-05 | 31 | $2.58 | 24,417 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-06 | 31 | $2.65 | 24,448 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-07 | 31 | $2.66 | 24,479 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-10 | 31 | $2.53 | 24,510 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-11 | 31 | $2.48 | 24,541 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-12 | 31 | $2.49 | 24,572 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-13 | 31 | $2.38 | 24,603 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-14 | 31 | $2.31 | 24,634 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-17 | 31 | $2.33 | 24,665 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-18 | 31 | $2.46 | 24,696 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-19 | 31 | $2.42 | 24,727 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-20 | 31 | $2.44 | 24,758 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-21 | 31 | $2.49 | 24,789 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-24 | 31 | $2.38 | 24,820 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-25 | 31 | $2.44 | 24,851 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-26 | 31 | $2.42 | 24,882 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-27 | 31 | $2.49 | 24,913 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-28 | 31 | $2.52 | 24,944 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-10-31 | 31 | $2.54 | 24,975 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.